Contents
Download PDF
pdf Download XML
697 Views
119 Downloads
Share this article
Case Report | Volume 13 Issue:2 (, 2023) | Pages 930 - 932
Imatinib Induced Iron Overload
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
May 18, 2023
Abstract

Imatinib is used in treatment of CML with Philadelphia chromosome positivity. Hepatotoxicity grade1-4 is described in literature. There is a case report of imatinib induced iron overload in a 46 year old male after 8 months of treatment with imatinib which is to our knowledge the only  in this regard. We report case of a 60 year old man who was on treatment for BCR-ABL positive CML for past 10 years now presenting with features of hepatic hemosiderosis. After ruling out known congenital and acquired causes the case can be attributed to Imatinib therapy.
Keywords
Imatinib CML
Philadelphia
BCR-ABL
Recommended Articles
Research Article
Lipid Profile Analysis in Chronic Alcoholic Patients: An Observational Study in A Tertiary Care Hospital
Kumbha Dhanusha, 
...
Renimadugu Padmavathi
Published: 22/08/2025
Download PDF
Research Article
Effect of OM meditation on cardiovascular parameters
Romil Warkari, 
...
Nikhil Gode
Published: 22/08/2025
Download PDF
Research Article
Study of Electrocardiography and 2d Echocardiography in Patients with Left Ventricular Hypertrophy
Shikhar Sahu, 
...
R.K. Jha
Published: 22/08/2025
Download PDF
Research Article
Endotracheal Size Estimation in Children: What is Latest? Different Methods and Correlation – A Prospective Observational Study
Padmavathi vigrahala, 
...
Bh. K. Vamsikrishna
Published: 22/08/2025
Download PDF
Chat on WhatsApp
European Journal of Cardiovascular Medicine
Open Access
Contact
  • +91 9063922599
  • +91 9063922599
  • editor@healthcare-bulletin.co.uk
Copyright © EJCM Publisher. All Rights Reserved.